Smith and Nephew, the medical technology business, has agreed to form a joint venture with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, to further develop its Biologics and Clinical Therapies division. The new entity, called Bioventus, will be 51% owned by Essex Woodlands and 49% by Smith & Nephew.
More to follow ...
By Rupert Hargreaves Published
Revealed: Best funds for DIY investors
Wondering where to put your money? With thousands of investment options, which funds, ETFs, trusts are the best? Bestinvest has just released it’s best funds list - we have all the details to help you strengthen your portfolio
By Kalpana Fitzpatrick Last updated